Skip to main content

Table 2 Genotype and allele distributions of TGF-β1 polymorphisms in NPC cases and controls. Odd Ratios obtained by univariate and multivariate analyses

From: No association between TGF-β1 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control study

Polymorphism

Cases n (%)

Controls n (%)

OR (CI 95 %)a

P-value

OR (CI 95 %)b

P-value

TGF-β1 −509

 Genotype

  CC

127 (39.20)

120 (37.03)

1.00

-

1.00

-

  CT

153 (47.22)

148 (45.68)

0.97 (0.69–1.36)

0.891

0.97 (0.69–1.37)

0.879

  TT

44 (13.58)

56 (17.29)

0.74 (0.46–1.18)

0.211

0.73 (0.45–1.17)

0.194

 Allele

  C

407 (62.47)

388 (59.87)

1.00

-

1.00

-

  T

241 (37.53)

260 (40.12)

0.88 (0.70–1.10)

0.278

0.87 (0.70–1.10)

0.251

TGF–β1 869

 Genotype

  TT

132 (36.57)

119 (35.52)

1.00

-

1.00

-

  TC

165 (45.70)

149 (44.48)

0.99 (0.71–1.39)

0.992

0.99 (0.71–1.38)

0.955

  CC

64 (17.72)

67 (20.00)

0.86 (0.56–1.31)

0.488

0.80 (0.52–1.23)

0.312

 Allele

  T

429 (59.91)

387 (57.76)

1.00

-

1.00

-

  C

293 (40.09)

283 (42.23)

0.93 (0.75–1.15)

0.530

0.92 (0.75–1.14)

0.453

  1. n number of subjects
  2. aUnadjusted Odds ratios and confidence interval for case-control comparison
  3. bOdds ratios and confidence interval adjusted on age, sex and country